Deposition of viprostol (a synthetic PGE2 vasodilator) in the skin following topical administration to laboratory animals.
1. Topical application of 14C-viprostol, a synthetic prostaglandin E2 analogue, to laboratory animals resulted in a significant depot of radioactivity in the skin at the application site in all species studied: mouse, rat, guinea pig, rabbit and monkey, with longer residence times in the larger species. 2. The location of the 14C-label in the skin in mice and monkeys was determined by microscopic autoradiography. Evaluation of the autoradiograms show rapid penetration of the drug into the skin via the hair follicles. 3. In mouse distribution of radioactivity was evident in the stratum corneum and down the hair shafts by 30 min. after dosing. By 2 h radioactivity was also observed throughout the viable epidermis; in the dermis only the hair shafts contained significant radioactivity. At 72 h after dose removal, radioactivity was evident only in the hair follicles and hair shaft. 4. In monkey the residence time of radioactivity in the skin was significantly longer than in mouse, but the general distribution pattern was similar in both species. 5. The presence of viprostol in the hair follicles and epidermal layer after topical administration is consistent with its extensive skin metabolism previously reported.
D000287:Administration, Topical; D000818:Animals; D001345:Autoradiography; D001711:Biotransformation; D015232:Dinoprostone / Q000031:analogs & derivatives*; D006168:Guinea Pigs; D000882:Haplorhini; D051379:Mice; D011459:Prostaglandins E, Synthetic / Q000493:pharmacokinetics* / Q000600:supply & distribution; D011465:Prostaglandins, Synthetic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption; D013045:Species Specificity
D011459:Prostaglandins E, Synthetic; D011465:Prostaglandins, Synthetic; D015232:Dinoprostone; C034232:viprostol